Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evidence for Potassium Restriction in Hemodialysis (EvoKe-HD) Pilot Parallel Randomized Controlled Trial

NCT06120608 is registered in ClinicalTrials.gov with Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal as lead sponsor.

NCT NCT06120608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06120608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evidence for Potassium Restriction in Hemodialysis (EvoKe-HD) Pilot Parallel Randomized Controlled Trial
Lead sponsor
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 17, 2025
Completion date
March 12, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia, diminished renal excretion